WELL Health Technologies Corp. (TSE:WELL – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is C$6.96.
WELL has been the subject of several analyst reports. CIBC raised their target price on shares of WELL Health Technologies from C$4.75 to C$5.00 in a report on Friday, August 16th. Stifel Nicolaus decreased their price target on WELL Health Technologies from C$11.00 to C$10.00 in a research note on Monday, April 29th.
View Our Latest Analysis on WELL Health Technologies
Insiders Place Their Bets
WELL Health Technologies Stock Up 2.4 %
TSE WELL opened at C$4.68 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.25 and a debt-to-equity ratio of 41.57. WELL Health Technologies has a 52 week low of C$3.41 and a 52 week high of C$5.05. The firm has a market capitalization of C$1.17 billion, a price-to-earnings ratio of 8.21, a PEG ratio of -1.93 and a beta of 1.21. The company has a fifty day moving average of C$4.64 and a two-hundred day moving average of C$4.09.
About WELL Health Technologies
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.
Featured Stories
- Five stocks we like better than WELL Health Technologies
- Stock Dividend Cuts Happen Are You Ready?
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- Energy and Oil Stocks Explained
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- What Do S&P 500 Stocks Tell Investors About the Market?
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.